Certain health conditions, including autoimmune disease and arthritis, can cause ankle pain without an obvious injury. You’re strolling along when suddenly a pain shoots through your ankle for no ...

Mobile carrier KT is facing mounting scrutiny after a government investigation found the company concealed a major malware infection last year. According to a joint government-private investigation ...

Dana Santas, known as the “Mobility Maker,” is a certified strength and conditioning specialist and mind-body coach in professional sports, and is the author of the book “Practical Solutions for Back ...

New York Giants rookie running back Cam Skattebo exited Week 8's game vs. the Philadelphia Eagles with a gruesome ankle injury. The injury occurred midway through the second quarter as Skattebo ...

Cam Skattebo’s promising start to his rookie season was cut short on Sunday after he suffered a gruesome injury in the New York Giants’ loss to the Philadelphia Eagles that warranted no replays being ...

PHILADELPHIA -- New York Giants running back Cam Skattebo remains hospitalized after undergoing surgery Sunday night in Philadelphia to repair an open dislocation of his right ankle, sources told ESPN ...

IS OUR FOOTWEAR, BUT THAT SWITCH CAN REVEAL PROBLEMS CREATED OVER TIME BY A LACK OF SUPPORT. DOCTOR VAN DEN PATEL ORTHOPEDIC, FOOT AND ANKLE SURGEON AT MERCY MEDICAL CENTER, SAYS SOME PATIENTS DEVELOP ...

Knee pain is frustrating, limiting — and common. By 55, approximately 1 in 4 adults suffer from knee pain, which can be caused by arthritis, overuse injury, tendonitis, and even simple wear and tear.

Living with back pain can feel frustrating and limiting – and it can feel impossible to do some of the activities you love. Let’s start with the bad news: Shoes are almost never the (sole) cause of ...

I can’t tell you where I first saw mouth tape. Was it while investigating the intense morning shed routines on TikTok? Or perhaps an influencer who insinuated that using mouth tape at night would give ...

Kymera Therapeutics said Sanofi has pulled the plug on the most advanced drug candidate in the companies' partnership aimed at immune-inflammatory diseases but plans to advance a second candidate into ...

Kymera's KT-621 shows promising STAT6 degradation in Phase 1 trials, with favorable safety and planned further studies in 2025. KT-621 demonstrated superior Th2 biomarker reductions compared to ...